Keeping your team motivated when FDA approval isn’t guaranteed

Surviving the long road to FDA approval isn’t just about building great technology — it’s about keeping your team motivated, ...
RAPS

Swissmedic survey finds drug approval timelines slower than EMA, FDA

A new study by Swissmedic shows that it takes significantly more time to authorize new drugs in Switzerland than in the EU or US, and the gap is growing compared to the agency’s previous report.

FDA’s AI Push Ignites a new Biotech Arms Race and Totaligent may be quietly Positioning Itself at the Center

This shift is particularly meaningful for companies operating outside traditional pharmaceutical pipelines and, as AI reduces bottlenecks in trials, the next constraint becomes commercialization: how ...

FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder

BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly ...
Morning Overview on MSN

FDA says "manipulated" data backed approval, moves to withdraw the drug

The FDA has moved to pull Tavneos (avacopan) from the U.S. market, alleging that manipulated clinical trial data propped up ...